Posted by john on August 20th, 2006 — in Ultram News
Terminally-ill cancer patients can finally hope to live a pain-free life without the daily needle pricks, thanks to a new mode of pain relief which has been perfected by doctors at the Armed Forces Medical College (AFMC) here.
Medically referred to as the para vertebral neurolytic block, wherein a mixture of local anaesthetic and absolute (100%) […]
No Comments »
Posted by john on August 19th, 2006 — in Ultram News
Several months after injuring my shoulder in October 2004, I flew to my hometown of Houston and paid out of pocket to consult a trusted family doctor about the pain that inexplicably wouldn’t go away. He examined my clothed torso for about 15 seconds before offering this perfunctory analysis: “You’re getting older, and your body’s […]
No Comments »
Posted by john on August 14th, 2006 — in Ultram News
Why is it so difficult to get treatment for pain in this region? It seems the most compassion one can get in Billings is the offer of a bullet to bite when the pain gets too bad.
I suffer from rheumatoid arthritis. I no longer attend my grandchildren’s sport events. Sitting on bleachers for even a […]
No Comments »
Posted by john on August 11th, 2006 — in Ultram News
Drugmaker Biovail Corp. (TSX:BVF) is revising some of its product revenue forecasts after second-quarter profit soared to $80.6 million US from a year-earlier $3.7 million US.
Diluted earnings per share for the quarter ended June 30 rose to 50 cents from two cents, the Toronto-based company said Thursday.
Revenues increased to $252.8 million US from $216.2 million. […]
No Comments »
Posted by john on August 7th, 2006 — in Ultram News
Chemotherapy is the use of anti-cancer (cytotoxic) drugs to destroy cancer cells (including leukemia and lymphomas). There are more than 50 different chemotherapy drugs and some are given on their own, but often several drugs may be combined (this is known as combination chemotherapy).
The type of treatment given for cancer depends on many things, particularly […]
No Comments »
Posted by john on August 6th, 2006 — in Ultram News
Biovail Corp. shares plunged 25 per cent yesterday, erasing almost $1 billion of market value, after the Canadian drugmaker lost a court decision that may open the way to quicker generic competition for its most profitable product.
A California judge ruled on Tuesday that Anchen Pharmaceuticals Inc.’s planned generic version of the once-a-day anti-depressant Wellbutrin XL […]
No Comments »